Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Is birthweight associated with total and aggressive/lethal prostate cancer risks? A systematic review and meta-analysis
Ist Teil von
British journal of cancer, 2016-03, Vol.114 (7), p.839-848
Ort / Verlag
London: Nature Publishing Group UK
Erscheinungsjahr
2016
Quelle
MEDLINE
Beschreibungen/Notizen
Background:
It has been hypothesised that intrauterine exposures are important for subsequent prostate cancer risk. Prior epidemiological studies have used birthweight as a proxy of cumulative intrauterine exposures to test this hypothesis, but results have been inconsistent partly because of limited statistical power.
Methods:
We investigated birthweight in relation to prostate cancer in the Medical Research Council (MRC) National Survey of Health and Development (NSHD) using Cox proportional hazards models. We then conducted a meta-analysis of birthweight in relation to total and aggressive/lethal prostate cancer risks, combining results from the NSHD analysis with 13 additional studies on this relationship identified from a systematic search in four major scientific literature databases through January 2015.
Results:
Random-effects models found that per kg increase in birthweight was positively associated with total (OR=1.02, 95% confidence interval (95% CI)=1.00, 1.05;
I
2
=13%) and aggressive/lethal prostate cancer (OR=1.08, 95% CI=0.99, 1.19;
I
2
=40%). Sensitivity analyses restricted to studies with birthweight extracted from medical records demonstrated stronger positive associations with total (OR=1.11, 95% CI=1.03, 1.19;
I
2
=0%) and aggressive/lethal (OR=1.37, 95% CI=1.09, 1.74;
I
2
=0%) prostate cancer. These studies heavily overlapped with those based in Nordic countries.
Conclusions:
This study provides evidence that heavier birthweight may be associated with modest increased risks of total and aggressive/lethal prostate cancer, which supports the hypothesis that intrauterine exposures may be related to subsequent prostate cancer risks.